About Index Trending news
Analyze
Pricing
ViaCyte

ViaCyte

ViaCyte

Viacyte is a regenerative medicine company dedicated to improving the way diabetes patients are treated.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Grant
$3,900,000
Grant
$16,600,000
Employees

Team size

50+
Locations
HQ
Xconomy

ViaCyte Raises $10M, Moves to Human Trial with New Diabetes Product

Robotics Health Science
$3,900,000 Grant
The San Diego Union-Tribune

CIRM grants ViaCyte $3.9 million for diabetes stem cell therapy

Xconomy

ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics

Science Health